Associated Papers
Homozygous p.Val89Leu plays an important pathogenic role in 5α-reductase type 2 deficiency patients with homozygous p.Arg246Gln in SRD5A2.
Arya S et al.
European Journal of Endocrinology, 2020
Androgen metabolic genes in prostate cancer predisposition and progression.
Makridakis NM et al.
Frontiers in Bioscience : a Journal and Virtual Library, 2005
Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride.
Makridakis N et al.
Journal of Molecular Endocrinology, 2005
Identification and characterization of somatic steroid 5alpha-reductase (SRD5A2) mutations in human prostate cancer tissue.
Makridakis N et al.
Oncogene, 2004
Select a paper to view details